Chonluten: One Peptide, Two Linings
A three-amino-acid sequence studied across both lung and gut tissue — unusual in a family built on one peptide per organ, and there is a reason for it.
What Is Chonluten?
Chonluten is a synthesised tripeptide from the Khavinson family, studied in connection with both bronchial and gastrointestinal mucosa. That dual target is worth noticing, because the family’s whole design principle is tissue specificity.
Why lung and gut belong together, in plain language: they seem like completely different organs — one handles air, the other food. But look at what they have in common: both are linings that separate you from the outside world while still having to let things through. Both are mucosal surfaces, both carry heavy immune traffic, and both are places where the body must decide continuously what to admit and what to repel. They are less like two different rooms and more like two doors of the same building, fitted with the same kind of lock. A peptide aimed at that kind of surface is not necessarily confused about which organ it belongs to.
What the Research Examines
Published work examines Chonluten in respiratory tissue and in gastric and intestinal mucosa, looking at epithelial maintenance and responses to inflammatory stress.
The evidence base is small, preclinical, and drawn chiefly from the originating institute. There is no regulatory approval in any jurisdiction.
Why One Peptide for Two Different Organs
The bioregulator programme is built on one peptide per organ, which makes Chonluten look like an exception. It is studied across both lung and gut. There is a reason, and it is a genuinely interesting piece of biology.
Lung and gut are the same tissue, separated early. In the developing embryo both arise from the same sheet — the endoderm — and the respiratory tract buds off the digestive tract before either becomes recognisable. They are siblings, not neighbours.
They also solve the same problem. Both are surfaces where the outside world is allowed inside the body, and both must let some things through while refusing others: oxygen but not soot, nutrients but not bacteria. That is the same engineering brief written twice.
Think of two branches of the same business, one handling air and one handling food. Different premises and different stock, and if you looked at their operating manuals you would find much of the wording identical — because the underlying job, admitting the useful and excluding the rest, never changed.
A single peptide studied across both is therefore less strange than it first appears. Whether the shared origin translates into a shared response is exactly the open question.
Frequently Asked Questions
Compiled by the Southern Pacific Labs research team. Last updated July 2026.
Published References
- Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
- Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
- Khavinson VKh. “Peptides and Ageing.” Neuro endocrinology letters, 2002. PubMed
- Fedoreyeva LI, Kireev II, Khavinson VKh, et al. “Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.” Biochemistry. Biokhimiia, 2011. PubMed
Related Research Guides
More in Bioregulators & Neuropeptides
The whole Khavinson system — one peptide per organ, and the honest state of the evidence.
Read guide →Respiratory BioregulatorThe other respiratory member of the family.
Read guide →Anti-Inflammatory TripeptideA far better-evidenced tripeptide active in gut mucosal tissue.
Read guide →